Overview

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To study the safety and feasibility of stereotactic radiation dose escalation following neoadjuvant chemotherapy with concurrent conventionally fractionated radiation, by evaluating the acute and late toxicity of treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Treatments:
Capecitabine
Carboplatin
Deoxyglucose
Fluorodeoxyglucose F18
Fluorouracil